Viewing Study NCT06796504


Ignite Creation Date: 2025-12-24 @ 9:20 PM
Ignite Modification Date: 2025-12-25 @ 7:07 PM
Study NCT ID: NCT06796504
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-01-28
First Post: 2025-01-22
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot Study
Sponsor: SetPoint Medical Corporation
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module